“They” say that you are considered newly diagnosed for the first 2 1/2 to 3 years after your Multiple Sclerosis diagnosis. It seems like only yesterday that I posted my “Year One” article. It seems like only yesterday that I was diagnosed! Somehow, enough time has passed that I find myself at a point where I have been living with Multiple Sclerosis for four years.
BG-12 (Dimethyl Fumarate) has not yet been approved for use, but trials have been overwhelmingly positive for this low-risk oral drug. Approved for Fast Track (10 months of review) by the FDA on February 28 2012, BG-12 should be available to Relapsing-Remitting MS patients and possibly for individuals with rheumatoid arthritis as a pill taken 2 or 3 times daily before 2013. The European Union, Canada and Switzerland are also currently reviewing this drug.
In addition to rheumatoid arthritis, Dimethyl Fumarate (DMF) is also being studied for its effects on lupus and cancer. DMF is a Fumaric Acid Ester which has been used to treat psoriasis since 1959.
Neurologists around the world are already planning to make this their go-to first line treatment for patients with Multiple Sclerosis even though Biogen Idec (the company behind Avonex and Tysabri) has not yet released a price profile of the drug. Why is BG-12 expected to quickly become the world’s leading MS treatment?
Happy New Year! For most of 2011 I have focused solely on my own journey to obtain Gilenya and continue using it. I threw away the needles and felt great about it. And what’s been going on in the meantime? Montel got CCSVI! A new stem cell trial without chemotherapy is almost underway! New medications (*ahem* BG-12) are winding their way through the pipeline! And also in that time, much has been discovered. Multiple Sclerosis Research has recently revealed more about the nature of the Multiple Sclerosis, a disease that needs ever more illumination.
These are the discoveries I find most exciting of all right now.
[Read more…] about Those Poor Mice: New Developments In Multiple Sclerosis Research